TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis
about
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASSWilms tumor 1 mutations in the pathogenesis of acute myeloid leukemiaRecent advances in understanding myelofibrosis and essential thrombocythemiaPhysiological and pathological implications of 5-hydroxymethylcytosine in diseasesEpigenetic regulators and their impact on therapy in acute myeloid leukemiaEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionCytogenetic and molecular abnormalities in chronic myelomonocytic leukemiaFunctions of TET Proteins in Hematopoietic TransformationIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Dysregulated metabolism contributes to oncogenesisMechanisms and functions of Tet protein-mediated 5-methylcytosine oxidationEngineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cellsMechanisms of epigenetic regulation of leukemia onset and progressionG17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cellsConnections between TET proteins and aberrant DNA modification in cancerMyeloid malignancies: mutations, models and managementMechanism and function of oxidative reversal of DNA and RNA methylationThe TET2 interactors and their links to hematological malignanciesJAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosisTet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural DevelopmentIDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.Role of TET enzymes in DNA methylation, development, and cancerDNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic DisordersEpigenetic mechanisms in heart development and diseaseDNA methylation and hydroxymethylation in stem cellsProperties and biological roles of TET proteins during embryogenesis and in hematopoiesisDNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaWT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferationAge-related clonal hematopoiesis associated with adverse outcomesTen-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in miceT-cell lymphomas, a challenging disease: types, treatments, and future.DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingSubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization.Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoThe anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine.
P2860
Q24312040-F34D6679-96A0-40F7-BE4A-BCAEDDDC5200Q26744111-5C66E125-AE71-46D7-B586-A96C58A813C5Q26748543-81DF2584-DCB7-4BEC-AA11-57B16E4C74CDQ26749375-20508F20-81E9-4F10-8E67-36399F0B4E17Q26765402-6E8267BD-F353-40DD-B3D2-A62019322D7EQ26766149-4AD0AB4A-11B7-41E7-B765-22996D9854EFQ26768600-4918AED7-A2AA-40D8-A539-4635C91409B2Q26778323-3FFE7D39-3A3F-4F85-8BAE-6FDBD807C413Q26779702-17813FFA-64AE-4E8A-9DBC-F870CED2496EQ26784630-9AD476B8-771F-4601-9290-8F508708D974Q26823896-994AED99-C599-43A2-B368-452A03034902Q26828777-4E2E759B-D182-4377-851B-63CB05C0B1F8Q26828997-F5AD133F-A2FF-4695-B772-B3D4BCBFE2D2Q26851510-AA9D0476-190D-4CB1-B74C-15CA9479FABCQ26861785-919240BE-E19D-404B-B519-84F21B6163C1Q26863411-2FD1037D-5F91-4288-86DB-B82CB66986EAQ26865671-FCC24E93-3C57-417A-A998-D78662347C5EQ27000577-062D6A2A-4BB8-43F8-B94C-85D10EBB3213Q27002361-1D600F0B-398A-4719-AB9F-204B4684EC91Q27002485-C0BB79F9-0603-435A-AABA-C30459FC6B62Q27012572-3E7AC475-3431-4325-A831-853548202774Q27334940-08F21033-16E1-407C-B452-51D8C5F041E7Q27675385-6BF2E690-0940-45E9-B2C0-5C71EBAD2A10Q27851701-839F99CB-0284-475A-BFD8-E36E05FE317CQ27853066-70DA6239-55C0-4B2C-9C1F-BCA29604E936Q27853198-52EA379B-AD23-4DAD-9D5D-1AAE44844E2AQ28068541-1034DA16-11DE-4059-A9A7-C074B136DDCAQ28073970-3768CBEB-6073-4472-91C8-8C439AD36107Q28081134-2C42DFC6-E185-4D1F-961E-6FD377B04D74Q28081499-D52592C7-E994-4152-96EC-3727171BBAA8Q28085708-50E41C89-80B5-497D-8C9A-EDCAE0B802D8Q28253465-CC2FCCFC-B0A5-4ADB-871B-91593EBA8C81Q28255707-B0070D8A-2B45-4FA9-B411-F26AAA9314A0Q28386602-B1A0500F-36E2-4E38-A173-3396506C9718Q28511594-CF3B27EA-D7C4-4026-8B56-39EE555B4675Q30244553-567C0B48-4D51-4DE3-92FA-969F82A21D80Q30355347-92E70539-07BE-48CF-9B35-20805C41A6F6Q30410213-9A74FB66-588B-49A3-8EBD-DBB0C04E03DEQ30413034-413269B8-EEAD-4821-BE97-DFD8DEB9A107Q30448762-50243BF6-77D0-4A4B-8315-A92FB44010F3
P2860
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis
description
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Juli 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/07/12)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/07/12)
@nl
наукова стаття, опублікована в липні 2011
@uk
مقالة علمية (نشرت في 12-7-2011)
@ar
name
TET2 inactivation results in p ...... t during human lymphomagenesis
@ast
TET2 inactivation results in p ...... t during human lymphomagenesis
@en
TET2 inactivation results in p ...... t during human lymphomagenesis
@nl
type
label
TET2 inactivation results in p ...... t during human lymphomagenesis
@ast
TET2 inactivation results in p ...... t during human lymphomagenesis
@en
TET2 inactivation results in p ...... t during human lymphomagenesis
@nl
prefLabel
TET2 inactivation results in p ...... t during human lymphomagenesis
@ast
TET2 inactivation results in p ...... t during human lymphomagenesis
@en
TET2 inactivation results in p ...... t during human lymphomagenesis
@nl
P2093
P50
P3181
P1433
P1476
TET2 inactivation results in p ...... t during human lymphomagenesis
@en
P2093
Bertrand Arnulf
Christian Bastard
Cécile K. Lopez
Hervé Tilly
Hélène Merle-Beral
Lucy Godley
Marcio Do Cruzeiro
Michaëla Fontenay
Olivier A. Bernard
Philippe Dessen
P3181
P356
10.1016/J.CCR.2011.06.003
P50
P577
2011-07-12T00:00:00Z